Table 1.
Characteristics | All Patients (N = 544) |
Community- Acquired Sepsis (N = 287) |
Healthcare- Associated Sepsis (N = 257) |
In-Hospital Death (N = 183) |
Alive and Out of Hospital (N = 361) |
|||||
---|---|---|---|---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | N | (%) | |||
Age group, years | 62.8 ± 17.9 (18–97) * | 63.2 ± 19 (18–97) * | 62.3 ± 16.6 (18–93) * | 65.3 ± 15.7 (19–95) * | 61.5 ± 18.8 (18–97) * | |||||
t-test = 0.53, 542 df, p = 0.53 | t-test = −2.32, 542 df, p = 0.02 | |||||||||
Sex | ||||||||||
Male | 282 | (51.8) | 149 | (51.9) | 133 | (51.8) | 96 | (52.5) | 186 | (51.5) |
Female | 262 | (48.2) | 138 | (48.1) | 124 | (48.2) | 87 | (47.5) | 175 | (48.5) |
χ2 = 0.002, 1 df, p = 0.97 | χ2 = 0.043, 1 df, p = 0.84 | |||||||||
Charlson’s index | 3.3 ± 2.5 (0–15) * | 3.2 ± 2.6 (0–15) * | 3.3 ± 2.4 (0–10) * | 3.3 ± 2.5 (0–15) * | 3.3 ± 2.5 (0–10) * | |||||
0 | 71 | (13) | 47 | (16.4) | 24 | (9.3) | 17 | (9.3) | 54 | (15) |
≥1 | 473 | (87) | 240 | (83.6) | 233 | (90.7) | 166 | (90.7) | 307 | (85) |
χ2 = 5.92, 1 df, p = 0.015 | χ2 = 3.44, 1 df, p = 0.06 | |||||||||
Diabetes | 140 | (25.7) | 85 | (29.6) | 55 | (21.4) | 46 | (21.4) | 94 | (26) |
χ2 = 5.79, 1 df, p = 0.029 | χ2 = 0.05, 1 df, p = 0.82 | |||||||||
Cancer | 146 | (26.8) | 50 | (17.4) | 96 | (37.6) | 44 | (24) | 102 | (28.3) |
χ2 = 27.4, 1 df, p < 0.001 | χ2 = 1.1, 1 df, p = 0.3 | |||||||||
Immune suppressed + | 109 | (20) | 45 | (15.7) | 64 | (24.9) | 27 | (14.8) | 82 | (22.7) |
χ2 = 7.2, 1 df, p = 0.007 | χ2 = 4.8, 1 df, p = 0.028 |
* Mean ± Standard Deviation (range). + Subjects with immune suppressive/autoimmune disorders or undergoing immune suppressive drug therapy, radiotherapy, and chemotherapy.